FDA Panel to Review OTC Birth Control Pills in May

FDA advisers will meet in May to discuss whether to allow the sale of Opill, a progestin-only birth control pill, over the counter. If approved, it would be the first birth control pill available over the counter in the U.S. The American Medical Association has called for allowing birth control pills to be sold over the counter, saying it could remove barriers and increase access to contraceptives. The push for prescription to over the counter comes amid legal battles regarding women's reproductive rights.